3Suda T, Takahashi T, Golstein P, et al. Molecular cloning and expressit on of the Fas ligand, a novel member of the tumor necrosis factor family [J]. Ce11,1993,75:1169- 1178. 被引量：1
4Bennett MW, O'connell J, O'sullivan GC, et al. The Fas counterattack in vivo: apoptotic depletion of tumor- infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma[ J]. J Immunol, 1998, 160( 11 ):5669- 5675. 被引量：1
5Trauth BC, Klas C, Peters AM J, et al. Monoclonal antibody mediated tumor regression by induction of apoptosis[ J ]. Science, 1989,245:301 - 305. 被引量：1
6Yonehava S, Ishii A, Yonehara M .A cell killing monoclonal antibody (anti - Fas) to a cell surface antigen co - down regulated with the receptor of tumor necrosis factor [ J]. J Exp Med, 1989,169:1747- 1756. 被引量：1
7Leithauser F, Dhein J, Mechtersheimer G, et al. Constitutive and induced expression of Apo - 1, a new member of the nerve growth factor / tumor necros is factor receptor superfamily, in normal and neoplastic cells [J]. Lab Invest, 1993,6 9(4):415 -429. 被引量：1
8Rensing- Ehl A, Frei K, Flury R, et al. Local Fas/Apo- 1 (CD95) ligand - mediated tumor cell killing in vivo [J]. Eur J Immunol, 1995,25:2253 - 2258. 被引量：1
9O'connell J, Benett JM, O'sullivan C, et al. The Fas counterattack: a molecular mechanism of tumor immune privilege [J]. Mol Med, 1997,3:294. 被引量：1
10Allison J,Georgiou HM,Strasser A,et al. Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune priviege upon islet allograft[J]. Proc Acad Sci USA, 1997,94:3 943 被引量：1
